SG10201600435UA - Vaccines And Compositions Against Streptococcus Pneumoniae - Google Patents

Vaccines And Compositions Against Streptococcus Pneumoniae

Info

Publication number
SG10201600435UA
SG10201600435UA SG10201600435UA SG10201600435UA SG10201600435UA SG 10201600435U A SG10201600435U A SG 10201600435UA SG 10201600435U A SG10201600435U A SG 10201600435UA SG 10201600435U A SG10201600435U A SG 10201600435UA SG 10201600435U A SG10201600435U A SG 10201600435UA
Authority
SG
Singapore
Prior art keywords
vaccines
streptococcus pneumoniae
compositions against
against streptococcus
compositions
Prior art date
Application number
SG10201600435UA
Other languages
English (en)
Inventor
Todd Gierahn
Richard Malley
Original Assignee
Genocea Biosciences Inc
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genocea Biosciences Inc, Childrens Medical Center filed Critical Genocea Biosciences Inc
Publication of SG10201600435UA publication Critical patent/SG10201600435UA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092Streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
SG10201600435UA 2011-01-20 2012-01-20 Vaccines And Compositions Against Streptococcus Pneumoniae SG10201600435UA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161434818P 2011-01-20 2011-01-20

Publications (1)

Publication Number Publication Date
SG10201600435UA true SG10201600435UA (en) 2016-02-26

Family

ID=46516136

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201600435UA SG10201600435UA (en) 2011-01-20 2012-01-20 Vaccines And Compositions Against Streptococcus Pneumoniae
SG2013055496A SG192060A1 (en) 2011-01-20 2012-01-20 Vaccines and compositions against streptococcus pneumoniae

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2013055496A SG192060A1 (en) 2011-01-20 2012-01-20 Vaccines and compositions against streptococcus pneumoniae

Country Status (14)

Country Link
US (2) US9393294B2 (ru)
EP (1) EP2665490B1 (ru)
JP (1) JP6126993B2 (ru)
KR (1) KR20140017554A (ru)
CN (2) CN103501809B (ru)
AU (2) AU2012207088A1 (ru)
BR (1) BR112013018642A2 (ru)
CA (1) CA2861313A1 (ru)
IL (1) IL227554A (ru)
MX (1) MX344120B (ru)
MY (1) MY163871A (ru)
RU (1) RU2623174C2 (ru)
SG (2) SG10201600435UA (ru)
WO (2) WO2012100234A1 (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011008548A1 (en) * 2009-06-29 2011-01-20 Genocea Biosciences, Inc. Vaccines and compositions against streptococcus pneumoniae
WO2011112906A2 (en) 2010-03-12 2011-09-15 Children's Medical Center Corporation Novel immunogens and methods for discovery and screening thereof
WO2012100234A1 (en) 2011-01-20 2012-07-26 Genocea Biosciences, Inc. Vaccines and compositions against streptococcus pneumoniae
EP2804627B1 (en) * 2012-01-20 2019-08-14 Genocea Biosciences Inc. Fused antigen vaccines and compositions against streptococcus pneumoniae
ES2959258T3 (es) 2013-02-07 2024-02-22 Childrens Medical Center Antígenos proteicos que proporcionan protección contra la colonización y/o la enfermedad neumocócicas
US10126305B2 (en) * 2013-06-25 2018-11-13 University of Pittsburg—Of the Commonwealth System of Higher Education Proteomic biomarkers of sepsis in elderly patients
KR101587859B1 (ko) * 2013-09-11 2016-01-25 한국기초과학지원연구원 폐렴연쇄상구균의 NagA 단백질을 포함하는 폐렴연쇄상구균의 감염 진단용 조성물
AU2014359292B2 (en) 2013-12-03 2019-02-28 Swiss Tropical And Public Health Institute Proline-rich peptides protective against S. pneumoniae
CN106822885B (zh) 2017-02-16 2020-06-30 清华大学 肺炎链球菌疫苗
GB201807380D0 (en) 2018-05-04 2018-06-20 Karlsson Roger Biomarkers for detecting microbial infection
BR112021004193A2 (pt) 2018-09-12 2021-05-25 Affinivax, Inc. vacinas pneumocócicas multivalentes
RU2701733C1 (ru) * 2018-12-14 2019-10-01 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Живая вакцина на основе штамма пробиотиков ENTEROCOCCUS FAECIUM L3 для профилактики инфекции, вызванной STREPTOCOCCUS PNEUMONIE

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2059692C (en) * 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
US5371197A (en) 1991-09-24 1994-12-06 Merck & Co., Inc. Protein-dimeric polysaccharide conjugate vaccine
US5474905A (en) * 1993-11-24 1995-12-12 Research Corporation Technologies Antibodies specific for streptococcus pneumoniae hemin/hemoglobin-binding antigens
US5505947A (en) 1994-05-27 1996-04-09 The University Of North Carolina At Chapel Hill Attenuating mutations in Venezuelan Equine Encephalitis virus
JP2000511769A (ja) 1996-04-02 2000-09-12 スミスクライン・ビーチャム・コーポレイション 新規化合物
DE69737125T3 (de) 1996-10-31 2015-02-26 Human Genome Sciences, Inc. Streptococcus pneumoniae-Antigene und Impfstoffe
CN1268178A (zh) 1997-05-06 2000-09-27 人体基因组科学有限公司 粪肠球菌多核苷酸和多肽
CA2294568A1 (en) 1997-06-20 1998-12-30 Human Genome Sciences, Inc. Lyme disease vaccines
US6800744B1 (en) 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US7122368B1 (en) 1997-07-02 2006-10-17 Sanofi Pasteur Limited Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US5882885A (en) 1997-07-17 1999-03-16 Smithkline Beecham Corporation Glycogen phosphorylase
US5994101A (en) 1997-07-18 1999-11-30 Smithkline Beecham Corporation DNA encoding gidA1 polypeptides
US6617156B1 (en) 1997-08-15 2003-09-09 Lynn A. Doucette-Stamm Nucleic acid and amino acid sequences relating to Enterococcus faecalis for diagnostics and therapeutics
US6248558B1 (en) 1998-03-31 2001-06-19 Vanderbilt University Sequence and method for genetic engineering of proteins with cell membrane translocating activity
EP1144640A3 (en) 1998-07-27 2001-11-28 Microbial Technics Limited Nucleic acids and proteins from streptococcus pneumoniae
GB9816337D0 (en) * 1998-07-27 1998-09-23 Cortecs Uk Ltd Proteins
NZ512574A (en) 1998-12-23 2004-03-26 Iaf Biochem Int Novel streptococcus antigens useful as vaccines
EP1185297B1 (en) 1999-06-10 2006-05-10 MedImmune, Inc. Streptococcus pneumoniae proteins and vaccines
US6887480B1 (en) 1999-06-10 2005-05-03 Medimmune, Inc. Streptococcus pneumoniae proteins and vaccines
HUP0203880A2 (hu) 1999-12-23 2003-03-28 Vmax Limited Virulencia gének, proteinek és alkalmazásuk
US6783939B2 (en) 2000-07-07 2004-08-31 Alphavax, Inc. Alphavirus vectors and virosomes with modified HIV genes for use in vaccines
EP2189473A3 (en) 2000-10-27 2010-08-11 Novartis Vaccines and Diagnostics S.r.l. Nucleic and proteins from streptococcus groups A & B
GB0107658D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
EP2261241A1 (en) 2001-04-16 2010-12-15 Wyeth Holdings Corporation Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
US20040029129A1 (en) 2001-10-25 2004-02-12 Liangsu Wang Identification of essential genes in microorganisms
US7314974B2 (en) 2002-02-21 2008-01-01 Monsanto Technology, Llc Expression of microbial proteins in plants for production of plants with improved properties
EP2275121B1 (en) 2002-04-02 2013-06-12 Ben Gurion University Of The Negev Research And Development Authority Protein-based streptococcus pneumoniae vaccines
US20090252756A1 (en) 2002-04-02 2009-10-08 Yaffa Mizrachi-Nebenzahl Protein-based streptococcus pneumoniae vaccines
US20070053924A1 (en) 2002-08-26 2007-03-08 Herve Tettelin Conserved and specific streptococcal genomes
WO2004020609A2 (en) 2002-08-30 2004-03-11 Tufts University Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection
US20050020613A1 (en) 2002-09-20 2005-01-27 Alpharma, Inc. Sustained release opioid formulations and method of use
CA2522238A1 (en) 2003-04-15 2004-10-28 Intercell Ag S. pneumoniae antigens
GB0318688D0 (en) 2003-08-08 2003-09-10 Chiron Srl Streptococcus pneumoniae knockout mutants
MX2007007033A (es) 2004-12-22 2007-08-03 Novartis Vaccines & Diagnostic Estreptococus del grupo b.
WO2006084466A2 (en) 2005-02-11 2006-08-17 Ace Biosciences A/S Surface-located streptococcus pneumoniae polypeptides
US20110177960A1 (en) 2006-03-10 2011-07-21 Ellen Murphy Microarray for monitoring gene expression in multiple strains of Streptococcus pneumoniae
PT2054431E (pt) 2006-06-09 2011-11-03 Novartis Ag Confórmeros de adesinas bacterianas
GB0700136D0 (en) 2007-01-04 2007-02-14 Glaxosmithkline Biolog Sa Process for manufacturing vaccines
WO2008119358A2 (en) 2007-03-30 2008-10-09 Ace Biosciences A/S Surface-located streptococcus pneumoniae polypeptides for use in vaccine compositions
WO2009011971A2 (en) 2007-05-18 2009-01-22 The Govt. Of The U.S.A. As Represented By The Secretary Of The Dept. Of Health And Human Services, Centers For Disease Control And Prevention Primers and probes for the detection of streptococcus pneumoniae
CN101848929A (zh) 2007-05-25 2010-09-29 诺华有限公司 肺炎链球菌菌毛抗原
US20100247547A1 (en) 2007-05-29 2010-09-30 Chen Dong Modulation of the th-17 cell mediated immune responses
GB0714963D0 (en) * 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
US20100278819A1 (en) 2007-09-14 2010-11-04 Katholieke Universiteit Leuven Streptococcus pneumoniae vaccines
US8466259B2 (en) 2007-12-07 2013-06-18 National Health Research Institutes Adjuvants
US7833776B2 (en) 2007-12-12 2010-11-16 National Health Research Institutes Lipidating sequences and use thereof for producing lipidated proteins in E. coli
WO2009114207A2 (en) 2008-03-14 2009-09-17 Sanofi Pasteur Biologics Co. Replication-defective flavivirus vaccines and vaccine vectors
AU2009266924B2 (en) 2008-07-01 2015-12-10 Genocea Biosciences, Inc. Antigen screening system
KR20110091560A (ko) 2008-12-03 2011-08-11 프로테아 벡신 테크놀로지스 엘티디. 글루타밀 tRNA 합성효소(GtS) 단편들
US8287880B2 (en) 2009-06-02 2012-10-16 National Health Research Institutes Lipidated vaccine against dengue virus infection
TWI409275B (zh) 2009-06-22 2013-09-21 Nat Health Research Institutes 脂質化腫瘤相關抗原及其免疫治療的組成物及方法
US20120100172A1 (en) 2009-06-25 2012-04-26 Michael Tal Immunogenic streptococcus pneumoniae peptides and peptide-multimers
WO2011008548A1 (en) * 2009-06-29 2011-01-20 Genocea Biosciences, Inc. Vaccines and compositions against streptococcus pneumoniae
WO2011064781A1 (en) 2009-11-30 2011-06-03 Ben-Gurion University Of The Negev Research And Development Authority S. pneumoniae adhesins
WO2011067758A2 (en) 2009-12-02 2011-06-09 Protea Vaccine Technologies Ltd. Immunogenic fragments and multimers from streptococcus pneumoniae proteins
JP5065434B2 (ja) 2010-04-06 2012-10-31 株式会社日立製作所 管理方法及び管理装置
WO2011128892A2 (en) 2010-04-12 2011-10-20 Protea Vaccine Technologies Ltd. Modified forms of pneumococcal surface immunogenic protein b (psipb)
US20110283062A1 (en) 2010-05-14 2011-11-17 Hitachi, Ltd. Storage apparatus and data retaining method for storage apparatus
WO2012100234A1 (en) 2011-01-20 2012-07-26 Genocea Biosciences, Inc. Vaccines and compositions against streptococcus pneumoniae

Also Published As

Publication number Publication date
EP2665490B1 (en) 2020-03-04
CA2861313A1 (en) 2012-07-26
NZ614460A (en) 2015-08-28
AU2012207089A1 (en) 2013-05-02
AU2012207088A1 (en) 2013-05-02
CN103501809B (zh) 2018-08-10
MX344120B (es) 2016-12-06
IL227554A0 (en) 2013-09-30
WO2012100233A1 (en) 2012-07-26
RU2013138563A (ru) 2015-02-27
US9393294B2 (en) 2016-07-19
MX2013008358A (es) 2013-09-02
US20170157234A1 (en) 2017-06-08
JP2014503002A (ja) 2014-02-06
IL227554A (en) 2016-10-31
SG192060A1 (en) 2013-08-30
WO2012100234A1 (en) 2012-07-26
CN103501809A (zh) 2014-01-08
RU2623174C2 (ru) 2017-06-22
AU2012207089B2 (en) 2016-04-14
KR20140017554A (ko) 2014-02-11
EP2665490A1 (en) 2013-11-27
US10188717B2 (en) 2019-01-29
BR112013018642A2 (pt) 2019-04-30
JP6126993B2 (ja) 2017-05-10
US20120189649A1 (en) 2012-07-26
CN105833260A (zh) 2016-08-10
MY163871A (en) 2017-10-31
EP2665490A4 (en) 2015-07-01

Similar Documents

Publication Publication Date Title
IL257533B (en) Immunotherapeutic compositions of muc1-shemer and their uses
SG10201600435UA (en) Vaccines And Compositions Against Streptococcus Pneumoniae
SG10201403702SA (en) Vaccines and compositions against streptococcus pneumoniae
HK1199694A1 (zh) 益生菌組合物和方法
ZA201408594B (en) Xylitol-based anti-mucosal compositions and related methods and compositions
EP2763665A4 (en) ANTIMICROBIAL COMPOSITIONS AND METHODS USING SAME
HK1210714A1 (en) Antibody formulations and uses thereof
EP2825196A4 (en) ADJUVANT AND VACCINE COMPOSITIONS
ZA201308537B (en) Vaccine against streptococcus pneumoniae
HK1206970A1 (en) Antigenic compositions and methods
GB201315350D0 (en) Methods and compositions
ZA201304517B (en) Composition for immunization against streptococcus pneumoniae
GB201315347D0 (en) Methods and compositions
EP2668044A4 (en) COMPOSITIONS AND THEIR USE
ZA201308892B (en) Compositions and methods
EP2766357A4 (en) MESOBILIVERDINE COMPOSITIONS AND METHOD THEREFOR
GB201106357D0 (en) Composition and uses thereof
EP2804627A4 (en) CONDENSED ANTIGEN VACCINES AND COMPOSITIONS AGAINST STREPTOCOCCUS PNEUMONIAE
HK1200724A1 (en) Chlamydia antigen compositions and uses thereof
EP2834635A4 (en) COMPOSITIONS WITH A HEPARINE ACCUMULATIVE AND METHOD THEREFOR
GB201120470D0 (en) Compositions and uses thereof
GB201116340D0 (en) Compositions and methods
GB201107454D0 (en) Compositions and uses
GB201101924D0 (en) Compositions and uses
TWM388902U (en) Dual-purpose pillow